rs41311139

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2

The NM_001242896.3(DEPDC5):​c.1165C>T​(p.Arg389Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0288 in 1,613,738 control chromosomes in the GnomAD database, including 765 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.019 ( 41 hom., cov: 32)
Exomes 𝑓: 0.030 ( 724 hom. )

Consequence

DEPDC5
NM_001242896.3 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.00
Variant links:
Genes affected
DEPDC5 (HGNC:18423): (DEP domain containing 5, GATOR1 subcomplex subunit) This gene encodes a member of the IML1 family of proteins involved in G-protein signaling pathways. The mechanistic target of rapamycin complex 1 (mTORC1) pathway regulates cell growth by sensing the availability of nutrients. The protein encoded by this gene is a component of the GATOR1 (GAP activity toward Rags) complex which inhibits the amino acid-sensing branch of the mTORC1 pathway. Mutations in this gene are associated with autosomal dominant familial focal epilepsy with variable foci. A single nucleotide polymorphism in an intron of this gene has been associated with an increased risk of hepatocellular carcinoma in individuals with chronic hepatitis C virus infection. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), DEPDC5. . Gene score misZ 2.6501 (greater than the threshold 3.09). Trascript score misZ 3.7275 (greater than threshold 3.09). GenCC has associacion of gene with focal epilepsy, Brugada syndrome, epilepsy, familial focal, with variable foci 1, familial focal epilepsy with variable foci, autosomal dominant epilepsy with auditory features, autosomal dominant nocturnal frontal lobe epilepsy.
BP4
Computational evidence support a benign effect (MetaRNN=0.0044102967).
BP6
Variant 22-31804863-C-T is Benign according to our data. Variant chr22-31804863-C-T is described in ClinVar as [Benign]. Clinvar id is 238672.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31804863-C-T is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0194 (2956/152276) while in subpopulation NFE AF= 0.032 (2177/68012). AF 95% confidence interval is 0.0309. There are 41 homozygotes in gnomad4. There are 1354 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 41 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
DEPDC5NM_001242896.3 linkuse as main transcriptc.1165C>T p.Arg389Cys missense_variant 17/43 ENST00000651528.2 NP_001229825.1 O75140-10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
DEPDC5ENST00000651528.2 linkuse as main transcriptc.1165C>T p.Arg389Cys missense_variant 17/43 NM_001242896.3 ENSP00000498382.1 O75140-10
ENSG00000285404ENST00000646701.1 linkuse as main transcriptc.1081C>T p.Arg361Cys missense_variant 15/21 ENSP00000496158.1 A0A2R8YF50

Frequencies

GnomAD3 genomes
AF:
0.0194
AC:
2956
AN:
152158
Hom.:
41
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00574
Gnomad AMI
AF:
0.0318
Gnomad AMR
AF:
0.0153
Gnomad ASJ
AF:
0.00778
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.0110
Gnomad FIN
AF:
0.0163
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0320
Gnomad OTH
AF:
0.0115
GnomAD3 exomes
AF:
0.0221
AC:
5519
AN:
249426
Hom.:
92
AF XY:
0.0218
AC XY:
2945
AN XY:
135324
show subpopulations
Gnomad AFR exome
AF:
0.00426
Gnomad AMR exome
AF:
0.0257
Gnomad ASJ exome
AF:
0.0111
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0139
Gnomad FIN exome
AF:
0.0200
Gnomad NFE exome
AF:
0.0306
Gnomad OTH exome
AF:
0.0223
GnomAD4 exome
AF:
0.0298
AC:
43568
AN:
1461462
Hom.:
724
Cov.:
30
AF XY:
0.0294
AC XY:
21366
AN XY:
727040
show subpopulations
Gnomad4 AFR exome
AF:
0.00463
Gnomad4 AMR exome
AF:
0.0245
Gnomad4 ASJ exome
AF:
0.0121
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.0148
Gnomad4 FIN exome
AF:
0.0208
Gnomad4 NFE exome
AF:
0.0342
Gnomad4 OTH exome
AF:
0.0260
GnomAD4 genome
AF:
0.0194
AC:
2956
AN:
152276
Hom.:
41
Cov.:
32
AF XY:
0.0182
AC XY:
1354
AN XY:
74472
show subpopulations
Gnomad4 AFR
AF:
0.00573
Gnomad4 AMR
AF:
0.0153
Gnomad4 ASJ
AF:
0.00778
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.0110
Gnomad4 FIN
AF:
0.0163
Gnomad4 NFE
AF:
0.0320
Gnomad4 OTH
AF:
0.0114
Alfa
AF:
0.0276
Hom.:
110
Bravo
AF:
0.0195
TwinsUK
AF:
0.0353
AC:
131
ALSPAC
AF:
0.0343
AC:
132
ESP6500AA
AF:
0.00634
AC:
24
ESP6500EA
AF:
0.0350
AC:
289
ExAC
AF:
0.0226
AC:
2729
Asia WGS
AF:
0.00346
AC:
12
AN:
3478
EpiCase
AF:
0.0294
EpiControl
AF:
0.0276

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsMay 23, 2018- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxJul 29, 2019- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsMar 14, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Familial focal epilepsy with variable foci Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.092
BayesDel_addAF
Benign
-0.59
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
17
DANN
Uncertain
0.99
DEOGEN2
Benign
0.021
.;.;.;.;.;.;.;.;T;.;.;.;.;.;.;T;.;.;.;.;.;.
Eigen
Benign
-0.38
Eigen_PC
Benign
-0.42
FATHMM_MKL
Benign
0.63
D
LIST_S2
Uncertain
0.94
D;D;D;D;D;D;D;D;D;D;.;.;D;D;.;.;D;D;.;D;D;D
MetaRNN
Benign
0.0044
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.1
L;.;.;L;L;.;.;L;L;.;L;.;L;.;L;L;.;.;L;L;.;.
PrimateAI
Benign
0.42
T
PROVEAN
Benign
-0.69
N;.;.;.;.;.;.;.;N;.;N;.;.;.;N;N;.;.;N;N;.;.
REVEL
Benign
0.052
Sift
Benign
0.16
T;.;.;.;.;.;.;.;T;.;T;.;.;.;T;T;.;.;T;T;.;.
Sift4G
Benign
0.18
T;.;.;.;.;.;.;.;T;.;T;.;.;.;T;T;.;.;T;T;.;.
Polyphen
0.90, 0.88
.;.;.;.;.;.;.;P;P;.;.;.;.;.;P;P;.;.;.;.;.;.
Vest4
0.16
MPC
0.54
ClinPred
0.013
T
GERP RS
-0.89
Varity_R
0.053

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs41311139; hg19: chr22-32200849; COSMIC: COSV56691655; COSMIC: COSV56691655; API